This is definitely overpriced.I guess this must be one of the most overpriced IPOs.The market is almost 1 billion $$$ for a company with losses and revenue less than 100 million $$$.Although i follow the medical sector primarily, the valuation of this stock really shocked me.glta
You are absolutely correct. Nothing at all special here, just a $4 stock trading at $20 for no reason except the analysts that know absolutely nothing about the space or the competition that CSOD cannot hope to beat.
This is very strange. Who in the world is buying this pig? $40m in rev, losing money, over crowded space, much bigger competitors, etc,etc.
give it 6 months to a year, after all goldman sachs needs to make their killing before this stock has an actual and real value.